Amgen Inc (AMGN)
269.58
-3.43
(-1.26%)
USD |
NASDAQ |
Apr 25, 16:00
268.01
-1.57
(-0.58%)
After-Hours: 16:31
Amgen Gross Profit (Quarterly): 5.084B for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 5.084B |
September 30, 2023 | 5.097B |
June 30, 2023 | 5.173B |
March 31, 2023 | 4.385B |
December 31, 2022 | 5.092B |
September 30, 2022 | 5.064B |
June 30, 2022 | 5.084B |
March 31, 2022 | 4.677B |
December 31, 2021 | 5.128B |
September 30, 2021 | 5.097B |
June 30, 2021 | 4.889B |
March 31, 2021 | 4.411B |
December 31, 2020 | 5.037B |
September 30, 2020 | 4.862B |
June 30, 2020 | 4.718B |
March 31, 2020 | 4.648B |
December 31, 2019 | 4.944B |
September 30, 2019 | 4.701B |
June 30, 2019 | 4.859B |
March 31, 2019 | 4.502B |
December 31, 2018 | 5.134B |
September 30, 2018 | 4.867B |
June 30, 2018 | 5.035B |
March 31, 2018 | 4.61B |
December 31, 2017 | 4.743B |
Date | Value |
---|---|
September 30, 2017 | 4.783B |
June 30, 2017 | 4.786B |
March 31, 2017 | 4.468B |
December 31, 2016 | 4.898B |
September 30, 2016 | 4.784B |
June 30, 2016 | 4.638B |
March 31, 2016 | 4.509B |
December 31, 2015 | 4.465B |
September 30, 2015 | 4.689B |
June 30, 2015 | 4.281B |
March 31, 2015 | 4.00B |
December 31, 2014 | 4.148B |
September 30, 2014 | 3.963B |
June 30, 2014 | 4.099B |
March 31, 2014 | 3.431B |
December 31, 2013 | 3.982B |
September 30, 2013 | 3.96B |
June 30, 2013 | 3.894B |
March 31, 2013 | 3.494B |
December 31, 2012 | 3.499B |
September 30, 2012 | 3.544B |
June 30, 2012 | 3.725B |
March 31, 2012 | 3.298B |
December 31, 2011 | 3.036B |
September 30, 2011 | 3.339B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
4.385B
Minimum
Mar 2023
5.173B
Maximum
Jun 2023
4.892B
Average
4.944B
Median
Dec 2019
Gross Profit (Quarterly) Benchmarks
Gilead Sciences Inc | 5.024B |
Johnson & Johnson | 14.87B |
Eli Lilly and Co | 7.565B |
Merck & Co Inc | 10.72B |
Vertex Pharmaceuticals Inc | 2.150B |